Patients who achieved HIV virologic suppression tended to be older and were more likely to report continued engagement in HIV care than those with persistent viremia.

Most children with JPsA show improved disease activity over the first 2 years of treatment, despite requiring early systemic therapy.

Dietary habits, including skipping breakfast and eating a later dinner, were associated with a higher risk for osteoporotic fracture.

Obeldesivir provided faster symptom relief but did not reduce hospitalization or all-cause mortality in high-risk nonhospitalized patients with COVID-19.